In the news | 26th Oct 2022

Embrace a cloud-only approach to streamline your validation

A cloud-only approach or infrastructure provides a vast array of benefits, including, first, offering peace of mind with automated disaster recovery, backups and upgrades; second, ease of use, with simple provisioning of test/sandbox environments as needed, as well as more streamlined deployments; and third, cloud solutions offer flexibility, with systems designed for high availability and resilience.

Read more about this topic in this article by Chris Ovett, Director of Cloud Solutions at IDBS, published in Drug Discovery & Development.

About IDBS Contact us

IDBS and SciBite bring enterprise ontologies and scientific data management together through a new partnership to unlock value from data through improved interoperability

1st March 2023 | 14:00

IDBS and SciBite announce a new partnership to shift the way research data platforms approach FAIR (Findable, Accessible, Interoperable, and Reusable) data.

New IDBS Polar data science capabilities democratize access to AI/ML-powered insights to accelerate BioPharma process optimization

24th February 2023 | 17:27

IDBS announces the launch of new data science capabilities for its Polar platform to accelerate BioPharma process optimization.

Tradeshow | Society for Laboratory Automation and Screening International Conference & Exhibition 2023 | February, 2023

21st February 2023 | 19:57

Come and join us at SLAS 2023 to learn how Polar can help you navigate your biopharma lifecycle

Tradeshow | BioProcess International US West | February, 2023

15th February 2023 | 20:41

Come and join us at BPI West to learn how Polar can help you navigate you biopharma lifecycle and how Skyland PIMS can help accelerate your biopharma development and manufacturing.